Natixis Advisors LLC Sells 4,337 Shares of Azenta, Inc. (NASDAQ:AZTA)

Natixis Advisors LLC lessened its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 1.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 374,113 shares of the company’s stock after selling 4,337 shares during the period. Natixis Advisors LLC owned approximately 0.82% of Azenta worth $18,706,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in AZTA. Victory Capital Management Inc. lifted its holdings in shares of Azenta by 4.0% during the 3rd quarter. Victory Capital Management Inc. now owns 27,281 shares of the company’s stock worth $1,321,000 after acquiring an additional 1,061 shares during the period. Quest Partners LLC lifted its holdings in shares of Azenta by 31.5% during the 3rd quarter. Quest Partners LLC now owns 7,941 shares of the company’s stock worth $385,000 after acquiring an additional 1,902 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of Azenta during the 3rd quarter worth approximately $1,979,000. Premier Fund Managers Ltd bought a new stake in shares of Azenta during the 3rd quarter worth approximately $686,000. Finally, Commerce Bank lifted its holdings in shares of Azenta by 42.8% during the 3rd quarter. Commerce Bank now owns 18,097 shares of the company’s stock worth $877,000 after acquiring an additional 5,428 shares during the period. Institutional investors own 99.08% of the company’s stock.

Azenta Price Performance

AZTA stock opened at $36.68 on Wednesday. Azenta, Inc. has a 1 year low of $35.56 and a 1 year high of $63.58. The company has a 50 day simple moving average of $47.57 and a 200 day simple moving average of $46.86. The stock has a market cap of $1.68 billion, a price-to-earnings ratio of -12.31 and a beta of 1.52.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, equities research analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AZTA has been the subject of a number of recent analyst reports. Evercore ISI upped their price target on shares of Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a report on Thursday, February 6th. Stephens reiterated an “overweight” rating and set a $60.00 price objective on shares of Azenta in a research report on Thursday, January 2nd. Needham & Company LLC upped their price objective on shares of Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a research report on Thursday, February 6th. Finally, TD Cowen upgraded shares of Azenta to a “hold” rating in a research report on Thursday, February 27th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Azenta has a consensus rating of “Hold” and an average price target of $58.75.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.